Foghorn Therapeutics furnishes investor presentation; no material new information

Foghorn Therapeutics Inc.

Company filed an investor presentation dated March 2025 under Regulation FD.
Presentation intended for use in meetings with investors; no financial results disclosed.
No specific numbers, deals, or guidance changes included in the filing.

item 7.01 item 9.01

Foghorn Therapeutics Inc. filing history →

Source: SEC EDGAR

accession 0001628280-25-014475

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.